|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.61 AUD | -0.58% |
|
-0.23% | -28.98% |
| 07-08 | Sanofi to stop disparaging rival flu vaccine to stave off EU antitrust fine | RE |
| 07-03 | Australian shares log best week in 3 as Fed-hike bets cool; banks, miners lead | RE |
Company Valuation: CSL Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 97,314 | 89,299 | 89,052 | 95,184 | 76,024 | 41,240 | - | - |
| Change | - | -8.24% | -0.28% | 6.89% | -20.13% | -45.75% | - | - |
| Enterprise Value (EV) 1 | 101,307 | 88,520 | 99,731 | 105,710 | 85,005 | 50,087 | 49,303 | 48,652 |
| Change | - | -12.62% | 12.66% | 5.99% | -19.59% | -41.08% | -1.56% | -1.32% |
| P/E | 41x | 38.6x | 40.8x | 36.1x | 25.4x | -46.2x | 28.7x | 13.3x |
| PBR | 11.6x | 6.13x | 5.64x | 5.48x | 3.93x | 2.53x | 2.52x | 2.29x |
| PEG | - | -4.91x | -7.25x | 1.8x | 1.9x | 0x | -0x | 0x |
| Capitalization / Revenue | 9.44x | 8.45x | 6.69x | 6.43x | 4.89x | 2.68x | 2.64x | 2.54x |
| EV / Revenue | 9.83x | 8.38x | 7.49x | 7.14x | 5.46x | 3.26x | 3.16x | 3x |
| EV / EBITDA | 27.2x | 24.6x | 25.6x | 22.3x | 16.5x | 9.62x | 9.53x | 8.98x |
| EV / EBIT | 32.4x | 30.2x | 32.5x | 27.7x | 19x | 11.2x | 11.1x | 10.5x |
| EV / FCF | 41.8x | 57.1x | 72.6x | 55.2x | 29.1x | 17.8x | 16.4x | 16.8x |
| FCF Yield | 2.39% | 1.75% | 1.38% | 1.81% | 3.44% | 5.61% | 6.11% | 5.95% |
| Dividend per Share 2 | 2.22 | 2.22 | 2.36 | 2.64 | 2.92 | 2.851 | 2.925 | 3.085 |
| Rate of return | 1.04% | 1.2% | 1.28% | 1.34% | 1.86% | 3.31% | 3.4% | 3.58% |
| EPS 2 | 5.21 | 4.8 | 4.53 | 5.45 | 6.17 | -1.865 | 3.003 | 6.493 |
| Distribution rate | 42.6% | 46.3% | 52.1% | 48.4% | 47.3% | -153% | 97.4% | 47.5% |
| Net sales 1 | 10,310 | 10,562 | 13,310 | 14,800 | 15,558 | 15,384 | 15,618 | 16,223 |
| EBITDA 1 | 3,720 | 3,596 | 3,900 | 4,750 | 5,151 | 5,206 | 5,172 | 5,417 |
| EBIT 1 | 3,130 | 2,927 | 3,069 | 3,812 | 4,468 | 4,462 | 4,447 | 4,645 |
| Net income 1 | 2,375 | 2,255 | 2,194 | 2,642 | 3,002 | -897.2 | 1,185 | 3,104 |
| Net Debt 1 | 3,993 | -778.6 | 10,679 | 10,526 | 8,981 | 8,847 | 8,063 | 7,413 |
| Reference price 2 | 213.82 | 185.38 | 184.61 | 196.96 | 157.01 | 86.11 | 86.11 | 86.11 |
| Nbr of stocks (in thousands) | 455,126 | 481,706 | 482,372 | 483,253 | 484,212 | 478,912 | - | - |
| Announcement Date | 17/08/21 | 16/08/22 | 14/08/23 | 12/08/24 | 18/08/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -46.16x | 3.26x | 9.62x | 3.31% | 41.24B | |
| 17.76x | 3.85x | 10.09x | 0.58% | 68.85B | |
| 25.64x | 5.3x | 15.59x | 0.61% | 52.13B | |
| 34.55x | 11.7x | 22.35x | -.--% | 43.46B | |
| 24.47x | 3.57x | 11.94x | -.--% | 30.41B | |
| -7.13x | 10.08x | -6.19x | -.--% | 24.53B | |
| 77.55x | - | - | -.--% | 23.42B | |
| 64.32x | 6.31x | 43.41x | -.--% | 19.75B | |
| 24.47x | 5.19x | 13.62x | -.--% | 16.57B | |
| -36.62x | 17.52x | -47.76x | -.--% | 15.95B | |
| Average | 17.89x | 7.42x | 8.07x | 0.45% | 33.63B | |
| Weighted average by Cap. | 16.75x | 6.49x | 10.89x | 0.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CSL Stock
- Valuation CSL Limited
Select your edition
All financial news and data tailored to specific country editions
